Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

TestPage MDR

From GxPlex

Revision as of 15:00, 29 June 2026 by Gxplex admin (talk | contribs) (style: remove width:100% from wikitable)

(diff) ← Older revision | Approved revision (diff) | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Document Information
Area of validity EU
Scope(s) MD
Document type Regulation
Document name Medical Device Regulation (EU) 2017/745
Version / Revision 2017/745, amended by 2023/607
Official source Official link
Language(s) EN, DE, FR (all EU official languages)
Status Current
Restricted access No

The Medical Device Regulation (MDR) 2017/745 replaces the former Medical Device Directive (MDD 93/42/EEC) and the Active Implantable Medical Device Directive (AIMDD 90/385/EEC). It establishes a uniform regulatory framework for medical devices across EU member states, with a strong focus on clinical evidence, post-market surveillance, and traceability.

Full application started on 26 May 2021. The amendment 2023/607 introduced a phased transition period for legacy devices.

Key references

Topic / Keyword(s) Category / Chapter Scope Linked document Description
Post-market surveillance, PMCF Clinical MD MDR 2017/745 – Articles 83–86 & Annex XIV Part B: Post-Market Surveillance and PMCF Articles 83–86 define the mandatory PMS system; Annex XIV Part B specifies PMCF requirements.
Unique Device Identification, UDI, Traceability Labelling MD MDR 2017/745 – Articles 27–29 & Annex VI: Unique Device Identification (UDI) Articles 27–29 and Annex VI establish the UDI system. All devices must carry a UDI carrier on label and packaging.
Clinical evaluation, Clinical evidence Clinical MD Article 61 and Annex XIV Part A define the clinical evaluation process and documentation requirements (CER). Page not yet created.

Related documents

Rate this page
0.00
(0 votes)